Skip to main content
. 2015 Mar 12;49(2):105–111. doi: 10.4132/jptm.2015.01.19

Fig. 2.

Fig. 2.

Clinical significance of C-reactive protein (CRP) immunoreactivity. (A) There is a significant difference in cancer-specific survival between patients with CRP grade 3 hepatocellular carcinomas (HCCs) and those with CRP grade 0, 1, and 2 HCCs. (B) There is no difference in recurrence-free survival between the two groups.